Showing results (61-70 of 967) with videos related to
Sort By:
Pageof 97
American Journal of Clinical Dermatology|October 15, 2009
Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulationsSteven R Feldman, Brad A YentzerJournal of Cutaneous Medicine and Surgery|March 17, 2015
Reasons for Treatment Changes in Patients With Moderate to Severe PsoriasisKathryn L Anderson, Steven R FeldmanDermatology Online Journal|July 2, 2020
Analyzing China's contributions to major dermatologic journals from the past 20 yearsJeremy K Bray, Steven R FeldmanCutis|November 23, 2016
Presenting treatment safety data: subjective interpretations of objective informationSara W Faulks, Steven R FeldmanAmerican Journal of Clinical Dermatology|May 13, 2015
Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexateMichael E Farhangian, Steven R FeldmanJournal of the American Academy of Dermatology|August 21, 2007
Interleukin-12, interleukin-23, and psoriasis: current prospectsDorothea C Torti, Steven R FeldmanDermatology Online Journal|September 8, 2020
The ethical implications of utilizing advertising techniques to increase biologic treatment willingness in patients with psoriasisJeremy K Bray, Steven R FeldmanDermatology Online Journal|April 5, 2021
Assessing the utility of the decoy effect on biologic treatment preferenceJeremy K Bray, Steven R FeldmanDermatology Online Journal|September 10, 2013
Tachyphylaxis to topical glucocorticoids; what is the evidence?Arash Taheri, Jacob Cantrell, Steven R FeldmanExpert Opinion on Investigational Drugs|October 9, 2018
Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizonAnisha Guda, Steven R Feldman, Lindsay StrowdPageof 97